scholarly journals SDHD Gene

2020 ◽  
Author(s):  
Keyword(s):  
2011 ◽  
Vol 97 (2) ◽  
pp. 214-220 ◽  
Author(s):  
Elisabetta Garibaldi ◽  
Sara Bresciani ◽  
Rocco Panaia ◽  
Elena Delmastro ◽  
Giuseppe Malinverni ◽  
...  

2001 ◽  
Vol 69 (6) ◽  
pp. 1186-1197 ◽  
Author(s):  
Anne-Paule Gimenez-Roqueplo ◽  
Judith Favier ◽  
Pierre Rustin ◽  
Jean-Jacques Mourad ◽  
Pierre-François Plouin ◽  
...  

Author(s):  
Wataru Habano ◽  
Tamotsu Sugai ◽  
Shin-Ichi Nakamura ◽  
Noriyuki Uesugi ◽  
Taro Higuchi ◽  
...  

2011 ◽  
Vol 121 (8) ◽  
pp. 1760-1764 ◽  
Author(s):  
Yang Zha ◽  
Xing-ming Chen ◽  
Ching-wan Lam ◽  
Soo-chin Lee ◽  
Sui-fan Tong ◽  
...  

2005 ◽  
Vol 14 (2) ◽  
pp. 109-114 ◽  
Author(s):  
Ana Velasco ◽  
Victor Palomar-Asenjo ◽  
Laura Ga??an ◽  
Lluis Catasus ◽  
Nuria Llecha ◽  
...  
Keyword(s):  

2003 ◽  
Vol 37 (2) ◽  
pp. 220-221 ◽  
Author(s):  
Alberto Cascón ◽  
Sergio Ruiz-Llorente ◽  
Arancha Cebrián ◽  
Rocío Letón ◽  
Dolores Tellería ◽  
...  
Keyword(s):  

2007 ◽  
Vol 137 (1) ◽  
pp. 126-129 ◽  
Author(s):  
Carsten Christof Boedeker ◽  
Hartmut P. H. Neumann ◽  
Wolfgang Maier ◽  
Birke Bausch ◽  
Jörg Schipper ◽  
...  

OBJECTIVE: Three of four paraganglioma syndromes (PGLs) have been characterized on a molecular genetic basis. PGL 1 is associated with mutations of the succinate dehydrogenase subunit D ( SDHD) gene, PGL 3 is caused by SDHC gene mutations, and PGL 4 is caused by SDHB gene mutations. The objective of this study was to investigate whether PGLs are associated with malignant head and neck paragangliomas (HNPs). STUDY DESIGN AND SETTING: Through November 2005, we screened 195 HNP patients for mutations of the genes SDHB, SDHC, and SDHD. RESULTS: We detected 5 SDHC, 13 SDHB, and 45 SDHD gene mutations. In seven SDHB mutation carriers, there were distant metastases. No signs of metastases were found in SDHC and SDHD patients. One patient with a sporadic HNP presented with locally metastatic disease. CONCLUSIONS: SDHB mutations are associated with a high rate of malignant HNPs. SIGNIFICANCE: In SDHB patients, a three-body region imaging and scintigraphy or DOPA-PET must be performed to exclude metastases.


Sign in / Sign up

Export Citation Format

Share Document